Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1979 1
1980 1
1981 1
1984 1
1985 1
1986 2
1988 1
1989 1
1991 1
1992 1
1993 2
1995 1
1996 5
1997 2
1998 3
1999 2
2000 6
2001 7
2002 3
2003 4
2004 6
2005 4
2006 4
2007 1
2008 4
2009 6
2010 6
2011 4
2012 3
2013 5
2014 2
2015 4
2016 5
2017 6
2018 3
2019 8
2020 7
2021 7
2022 11
2023 4
2024 9
2025 11
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Daprodustat and Heart Failure in CKD.
Cunningham JW, Claggett BL, Lopes RD, McMurray JJV, Perkovic V, Carroll K, Hiemstra T, Khavandi K, Lukas MA, Ranganathan P, Shannon J, van Adelsberg J, Singh AK, Solomon SD. Cunningham JW, et al. J Am Soc Nephrol. 2024 May 1;35(5):607-617. doi: 10.1681/ASN.0000000000000321. Epub 2024 Feb 22. J Am Soc Nephrol. 2024. PMID: 38383961 Free PMC article.
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
Randomisation was balanced by using randomly permuted blocks and was stratified by biologic history status and baseline SES-CD score. All patients who signed informed consent, who were not screening failures, and who received at least one dose of study treatment were inclu …
Randomisation was balanced by using randomly permuted blocks and was stratified by biologic history status and baseline SES-CD score. …
DEGRO 2004 : 10. Jahreskongress der Deutschen Gesellschaft für Radioonkologie.
Wendt TG, Gademann G, Pambor C, Grießbach I, von Specht H, Martin T, Baltas D, Kurek R, Röddiger S, Tunn UW, Zamboglou N, Eich HT, Staar S, Gossmann A, Hansemann K, Semrau R, Skripnitchenko R, Diehl V, Müller RP, Sehlen S, Willich N, Rühl U, Lukas P, Dühmke E, Engel K, Tabbert E, Bolck M, Knaack S, Annweiler H, Krempien R, Hoppe H, Harms W, Daeuber S, Schorr O, Treiber M, Debus J, Alber M, Paulsen F, Birkner M, Bakai A, Belka C, Budach W, Grosser KH, Kramer R, Kober B, Reinert M, Schneider P, Hertel A, Feldmann H, Csere P, Hoinkis C, Rothe G, Zahn P, Alheit H, Cavanaugh SX, Kupelian P, Reddy C, Pollock B, Fuss M, Roeddiger S, Dannenberg T, Rogge B, Drechsler D, Herrmann T, Alberti W, Schwarz R, Graefen M, Krüll A, Rudat V, Huland H, Fehr C, Baum C, Glocker S, Nüsslin F, Heil T, Lemnitzer H, Knips M, Baumgart O, Thiem W, Kloetzer KH, Hoffmann L, Neu B, Hültenschmidt B, Sautter-Bihl ML, Micke O, Seegenschmiedt MH, Köppen D, Klautke G, Fietkau R, Schultze J, Schlichting G, Koltze H, Kimmig B, Glatzel M, Fröhlich D, Bäsecke S, Krauß A, Strauß D, Buth KJ, Böhme R, Oehler W, Bottke D, Keilholz U, Heufelder K, Wiegel T, Hinkelbein W, Rödel C, Papadopoulos T, Munnes M, Wirtz R, Sauer R, R… See abstract for full author list ➔ Wendt TG, et al. Strahlenther Onkol. 2004 Jun;180 Suppl 1:5-87. doi: 10.1007/BF03356734. Strahlenther Onkol. 2004. PMID: 27137922 German. No abstract available.
Regiodivergent biosynthesis of bridged bicyclononanes.
Ernst L, Lyu H, Liu P, Paetz C, Sayed HMB, Meents T, Ma H, Beerhues L, El-Awaad I, Liu B. Ernst L, et al. Nat Commun. 2024 May 28;15(1):4525. doi: 10.1038/s41467-024-48879-w. Nat Commun. 2024. PMID: 38806518 Free PMC article.
Our studies elucidate the unique biochemistry that yields type A and B bicyclo[3.3.1]nonane cores in plants, thereby providing key building blocks for biotechnological efforts to sustainably produce these complex compounds for preclinical development....
Our studies elucidate the unique biochemistry that yields type A and B bicyclo[3.3.1]nonane cores in plants, thereby providing key building …
Adaptive radiation and social evolution of the ants.
Vizueta J, Xiong Z, Ding G, Larsen RS, Ran H, Gao Q, Stiller J, Dai W, Jiang W, Zhao J, Guo C, Zhang X, Zuo D, Zhong W, Schiøtt M, Liu C, Zhang H, Dai X, Andreu I, Shi Y, Tretter S, He D, Gautam S, Li Z, Hickey G, Ivens ABF, Meurville MP, Hita-Garcia F, Kass JM, Guénard B, Moreau C, Paten B, LeBoeuf AC, Economo EP; GAGA Consortium; Chapuisat M, Shik JZ, Ward PS, Heinze J, Schultz TR, Li Q, Dunn RR, Sanders NJ, Liu W, Schrader L, Boomsma JJ, Zhang G. Vizueta J, et al. Cell. 2025 Sep 4;188(18):4828-4848.e25. doi: 10.1016/j.cell.2025.05.030. Epub 2025 Jun 16. Cell. 2025. PMID: 40527318 Free PMC article.
Comparative analyses of 163 ant genomes, including newly generated whole-genome sequences of 145 ant species, reveal extensive genome rearrangements correlated with speciation rates. Meanwhile, conserved syntenic blocks are enriched with co-expressed genes involved in basa …
Comparative analyses of 163 ant genomes, including newly generated whole-genome sequences of 145 ant species, reveal extensive genome rearra …
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.
Sternberg C, Raigel M, Limberger T, Trachtová K, Schlederer M, Lindner D, Kodajova P, Yang J, Ziegler R, Kalla J, Stoiber S, Dey S, Zwolanek D, Neubauer HA, Oberhuber M, Redmer T, Hejret V, Tichy B, Tomberger M, Harbusch NS, Pencik J, Tangermann S, Bystry V, Persson JL, Egger G, Pospisilova S, Eferl R, Wolf P, Sternberg F, Högler S, Lagger S, Rose-John S, Kenner L. Sternberg C, et al. Mol Cancer. 2024 Oct 31;23(1):245. doi: 10.1186/s12943-024-02114-8. Mol Cancer. 2024. PMID: 39482716 Free PMC article.
We challenge the prevailing concept of blocking IL6ST/STAT3 signaling as a functional prostate cancer treatment and instead propose cell-autonomous IL6ST activation as a novel therapeutic strategy....
We challenge the prevailing concept of blocking IL6ST/STAT3 signaling as a functional prostate cancer treatment and instead propose c …
Abstracts der 3. Gemeinsamen Brachytherapiekonferenz SASRO/DEGRO/OEGRO.
Ott OJ, Strnad V, Pötter R, Hammer J, Hildebrandt G, Resch A, Kovács G, Beckmann MW, Sauer R, Niehoff P, Polgar C, Ostertag H, Major T, Eidtmann H, Jonat W, Kimmig B, Roddiger SJ, Kolotas C, Kuner RP, Martin T, Kurek R, Baltas D, Rogge B, Kautschur H, Hoffmann G, Pollow B, Kontova M, Zamboglou N, Ott O, Lotter M, Gallino A, Mahler F, Niewald M, Jafari F, Hennen B, Wisser L, Fleckenstein J, Rübe Ch, Böhm M, Micke O, Wagner W, Schäfer U, Willich N, Greiner RH, Pallas A, Pajic B, Collen T, Meurer N, Töpfer M, Ries G, Leutloff U, Frei S, Warszawski A, Baumann R, Möller T, Niedermeyer J, Karstens JH, Gripp S, Muskalla K, Pulte T, Ohmann C, Röddiger S, Dannenberg T, Tunn UW, Dimopoulos J, Schard G, Kirisits C, Lang S, Goldner G, Wachter S, Wachter-Gerstner N, Helbich T, Weise C, Bendel M, Kocher M, Müller RP, Engelmann U, Aebersold DM, Isaak B, Vetterli D, Kemmerling L, Thalmann G, Behrensmeier F, Mini R, Baier K, Wulf J, Nürnberg N, Egberts J, Galalae R, Maurer U, Maurer G, Lang K, Zumbé J, Block T, Czempiel H, Machtens S, Ponholzer A, Riedl A, Oismüller R, Somay C, Hawliczek R, Maier U, Madersbacher S, Hoinkis C, Winkler C, Lehmann D, Hakenberg O, Herrmann T, Messer PM, Gottfried HW, … See abstract for full author list ➔ Ott OJ, et al. Strahlenther Onkol. 2004 Jun;180 Suppl 1:109-28. doi: 10.1007/BF03356736. Strahlenther Onkol. 2004. PMID: 27137924 German. No abstract available.
Proteasome activator PA200 regulates myofibroblast differentiation.
Welk V, Meul T, Lukas C, Kammerl IE, Mulay SR, Schamberger AC, Semren N, Fernandez IE, Anders HJ, Günther A, Behr J, Eickelberg O, Korfei M, Meiners S. Welk V, et al. Sci Rep. 2019 Oct 23;9(1):15224. doi: 10.1038/s41598-019-51665-0. Sci Rep. 2019. PMID: 31645612 Free PMC article.
Proteasome activators serve as building blocks to adjust protein turnover in cell growth and differentiation. Understanding the cellular function of proteasome activation in more detail offers a new strategy for therapeutic targeting of proteasomal protein breakdown in dis …
Proteasome activators serve as building blocks to adjust protein turnover in cell growth and differentiation. Understanding the cellu …
Block Copolymer Giant Unilamellar Vesicles for High-Throughput Screening.
Heuberger L, Palivan C. Heuberger L, et al. Chimia (Aarau). 2022 Apr 27;76(4):350-353. doi: 10.2533/chimia.2022.350. Chimia (Aarau). 2022. PMID: 38069778 Free article.
Giant unilamellar vesicles (GUVs) can mimic cells in their morphological characteristics because their architecture is precisely controllable. We propose a block copolymer-based GUV system that can be used for high-throughput screening. Through droplet microfluidic methods …
Giant unilamellar vesicles (GUVs) can mimic cells in their morphological characteristics because their architecture is precisely controllabl …
153 results